Revel RX review

Most sites here make the flat-dose claim once, in a banner, and hope you do not test it. Revel makes it four times on one page — under each product as prose, as the label above them, and again in the plan copy — with no membership fee underneath and the consultation and shipping folded into the figure. It also does something rarer and more useful: it states the unit. "Prices shown are per month" reads as a calendar month, not the four-week cycle several providers here quietly bill on, which is the difference between twelve charges a year and thirteen. What is left is small but sits in an awkward place. The navigation advertises the entry price with an asterisk, and nothing on the page says what the asterisk qualifies — on a page whose whole pitch is that there is nothing behind the number, an unexplained mark beside it is the one thing a reader cannot check. No pharmacy is named either, and no state list is published.

Vs median

$80/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Flat at every dose

Price last updated

August 2026

Revel RX dispenses through a Not named facility. No bloodwork is required before you start. A clinician review is included in the price.

Revel RX makes the flat-dose promise more consistently than most providers here: it appears on both product cards as prose, again above them as the label "ALL DOSAGES · Flat monthly pricing", and again in the plan copy, with no membership fee underneath and the consultation and shipping folded in. It also states the unit plainly — "Prices shown are per month" — which reads as a calendar month rather than the four-week cycle several providers here quietly use, and that matters more than it sounds on a page selling a recurring charge. The one loose thread is an asterisk: the site's own navigation advertises "programs from $89/mo*" and nothing on the page says what the asterisk qualifies. On a page whose entire pitch is that there is nothing behind the number, an unexplained mark beside it is the one thing a reader cannot check.

The navigation advertises "from $89/mo*" and the asterisk is never explained anywhere on the page.

• No compounding pharmacy is named — only "state-licensed compounding pharmacies".
• No state list is published, and no dose ceiling is stated for either molecule.

Revel RX is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• What a flat price costs at a low dose
• The true annual cost of a plan